← Leaderboards
Karen A Kurdziel
Virginia Commonwealth University
$378,934
Attributed
$378,934
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5K · FY2006–07$5K$3.8K$2.5K$1.3K$0
'06
'07
Funding mix
By agency
NIH$378,934 · 3
By mechanism
R21$375,000 · 1
M01$3,934 · 2
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Kevin A Reynolds$10,412,938
- Stephen J O'Keefe$6,254,307
- Gordon L. Archer$6,493,828
- William Gregory Hundley$19,718,962
- Paul B Fisher$21,846,479
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionPaclitaxelP GlycoproteinPharmacokineticsPositron Emission TomographyCell LineAthymic MouseProtein Quantitation /DetectionProtein Structure FunctionRadionuclidesRadiotracerImmunocytochemistryFluorineBiomarkerMicroarray TechnologyMultidrug ResistanceNeoplastic CellXenotransplantationPre-ClinicalProceduresResearch PersonnelResourcesSourceSpecificity
Grant awards (4)
PHASE 2 STUDY OF COMBIDEX IN AUXILIARY NODE STAGING IN BREAST CANCER$1,404
M01 · FY2007 · RR · contact PI
PHASE 2 STUDY OF COMBIDEX IN AUXILIARY NODE STAGING IN BREAST CANCER$2,530
M01 · FY2006 · RR · contact PI
{F18}paclitaxel: an in vivo marker for MDR in tumors$187,500
R21 · FY2004 · CA
{F18}paclitaxel: an in vivo marker for MDR in tumors$187,500
R21 · FY2003 · CA